M&A Deal Summary |
|
|---|---|
| Date | 2024-02-05 |
| Target | InnoSyn |
| Sector | Life Science |
| Buyer(s) | Merieux Equity Partners |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 2009 |
| PE ASSETS | 1.5B EUR |
| Size | Large |
| Type | Sector Focused |
Mérieux Développement SAS is a venture and growth capital investment firm associated with family holding company Institut Mérieux. The Firm focuses on the health and nutrition sectors and will consider opportunities throughout North America and Europe. Mérieux Développement SAS was established in 2009 and is headquartered in Lyon, France.
| DEAL STATS | # |
|---|---|
| Overall | 22 of 24 |
| Sector: Life Science M&A | 11 of 11 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 9 of 10 |
| Country: Netherlands M&A | 1 of 1 |
| Year: 2024 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-01-09 |
Mabtech
Nacka Strand, Sweden Mabtech is a biotech company specialising in immune monitoring products used by companies and researchers on a global scale. Mabtech was founded in 1986 and is based in Nacka Strand, Sweden. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-07-03 |
GTP Bioways
Toulouse , France GTP Bioways is a contract development and manufacturing organisation (CDMO) offering uniquely customised process development and manufacturing services for biologics, antibody-drug conjugates and nanodrugs. GTP Bioways is based in Toulouse, France. |
Sell | - |
